Scientific Sessions 2024  /  Bridging the Gaps in the Management of Cardiac Amyloidosis - Where are we in 2024?  /  Disparities in the Management and Outcomes of Cardiac Amyloidosis in Underrepresented Populations. -how can we bridge the gaps? 10 minutes
Logo

American Heart Association

  2
  0

Final ID:

Disparities in the Management and Outcomes of Cardiac Amyloidosis in Underrepresented Populations. -how can we bridge the gaps? 10 minutes

  • Bullock-palmer, Renee  ( Deborah Heart and Lung Center , Browns Mills , New Jersey , United States )
  • Alexander, Kevin  ( Stanford University , Palo Alto , California , United States )
    • Author Disclosures:
    Renee Bullock-Palmer: DO NOT have relevant financial relationships | Kevin Alexander: DO have relevant financial relationships ; Consultant:Arbor Biotechnologies:Active (exists now) ; Consultant:Bristol Myers Squibb:Past (completed) ; Consultant:Prothena:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Intellia:Past (completed) ; Consultant:Alnylam:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Bridging the Gaps in the Management of Cardiac Amyloidosis - Where are we in 2024?

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Novel Therapies in the Management of Cardiac Amyloidosis and Access to Care

Falk Rodney, Kittleson Michelle, Cuddy Sarah

ATTR Genetic Screening and Subsequent Management in Underrepresented Populations-Bridging the Gap 10 minutes

Ruberg Frederick, Gillmore Julian

More abstracts from these authors:
Discussant: SCAN-MP

Alexander Kevin

CRISPR Quagmire: Weighing the Risks of Gene Therapies

Mammen Pradeep, Alexander Kevin

You have to be authorized to contact abstract author. Please, Login
Not Available